SYNENDOS Trademark

Trademark Overview


On Wednesday, November 10, 2021, a trademark application was filed for SYNENDOS with the United States Patent and Trademark Office. The USPTO has given the SYNENDOS trademark a serial number of 79330074. The federal status of this trademark filing is REGISTERED as of Tuesday, August 22, 2023. This trademark is owned by Synendos Therapeutics AG. The SYNENDOS trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical products for the treatment of neuropsychiatric, neurological and psychiatric diseases and disorders; pharmaceutical products for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, renal, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, inflammatory, immune, autoimmune, and genetic diseases and disorders; medical preparations and substances for the treatment of neuropsychiatric, neurological and psychiatric diseases and disorders; medical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, renal, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, inflammatory, immune, autoimmune, and genetic diseases and disorders; veterinary preparations ...

Medical services; veterinary services; hygienic care for human beings; medical and pharmaceutical consultancy services; medical tests for diagnostic or treatment purposes; conducting of medical examinations; consultations regarding pharmacology; pharmaceutical consulting, namely, consultant and information services relating to pharmaceutical products; conducting of chemical, medical and biological analyses for medical diagnosis being medical diagnostic testing services; consultancy and information services relating to medical products being pharmaceutical consultation services; medical analysis services relating to the treatment of patients; medical consultancy services; pharmacy advice being pharmaceutical consultation

Scientific and technological services, namely, scientific research, analysis, testing in the fields of pharmaceuticals, biopharmaceuticals, chemistry, biology, biochemistry; industrial analysis services, namely, industrial analysis in the fields of pharmaceuticals, biopharmaceuticals; industrial research services in the fields of pharmaceuticals, biopharmaceuticals; scientific research and development; scientific research; scientific analysis, namely, biological analysis, biochemical analysis, chemical analysis; conducting chemical and biological analyses for scientific purposes; conducting medical analysis for scientific purposes, namely, biological analysis, biochemical analysis, chemical analysis, blood analysis; medical research; pharmaceutical research; research in the fields of chemistry and biology; biotechnological research services; providing medical and scientific research information, namely, providing information and data with respect to medical and veterinary research and ...
synendos

General Information


Serial Number79330074
Word MarkSYNENDOS
Filing DateWednesday, November 10, 2021
Status700 - REGISTERED
Status DateTuesday, August 22, 2023
Registration Number7141186
Registration DateTuesday, August 22, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 6, 2023

Trademark Statements


Goods and ServicesPharmaceutical products for the treatment of neuropsychiatric, neurological and psychiatric diseases and disorders; pharmaceutical products for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, renal, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, inflammatory, immune, autoimmune, and genetic diseases and disorders; medical preparations and substances for the treatment of neuropsychiatric, neurological and psychiatric diseases and disorders; medical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, renal, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, inflammatory, immune, autoimmune, and genetic diseases and disorders; veterinary preparations and substances for the treatment of neuropsychiatric, neurological and psychiatric diseases and disorders; veterinary preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, renal, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, inflammatory, immune, autoimmune, and genetic diseases and disorders; sanitary preparations for medical use; medicines for pharmaceutical use for the treatment of neuropsychiatric, neurological and psychiatric diseases and disorders; medicines for pharmaceutical use for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, renal, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, inflammatory, immune, autoimmune, and genetic diseases and disorders; medicines for human medicine for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, renal, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, inflammatory, immune, autoimmune, and genetic diseases and disorders; medicines for human medicine, namely, pharmaceutical preparations acting on the central nervous system, biopharmaceutical preparations acting on the central nervous system, pharmaceutical agents affecting the peripheral nervous system and biopharmaceutical agents affecting the peripheral nervous system; medicines for human medicine, namely, medicines for treating biochemical imbalances in vivo; chemical-pharmaceutical preparations, namely, pharmaceutical preparations acting on the central nervous system, biopharmaceutical preparations acting on the central nervous system, pharmaceutical agents affecting the peripheral nervous system and biopharmaceutical agents affecting the peripheral nervous system; chemical preparations for medical use, namely, pharmaceutical preparations acting on the central nervous system, biopharmaceutical preparations acting on the central nervous system, pharmaceutical agents affecting the peripheral nervous system and biopharmaceutical agents affecting the peripheral nervous system; chemical preparations for pharmaceutical use, namely, pharmaceutical preparations acting on the central nervous system, biopharmaceutical preparations acting on the central nervous system, pharmaceutical agents affecting the peripheral nervous system and biopharmaceutical agents affecting the peripheral nervous system; chemical preparations for veterinary use, namely, pharmaceutical preparations acting on the central nervous system, biopharmaceutical preparations acting on the central nervous system, pharmaceutical agents affecting the peripheral nervous system and biopharmaceutical agents affecting the peripheral nervous system; chemical preparations for medical use for treating biochemical imbalances in vivo; chemical preparations for veterinary use for treating biochemical imbalances in vivo; diagnostic substances, preparations and agents for medical use
Goods and ServicesMedical services; veterinary services; hygienic care for human beings; medical and pharmaceutical consultancy services; medical tests for diagnostic or treatment purposes; conducting of medical examinations; consultations regarding pharmacology; pharmaceutical consulting, namely, consultant and information services relating to pharmaceutical products; conducting of chemical, medical and biological analyses for medical diagnosis being medical diagnostic testing services; consultancy and information services relating to medical products being pharmaceutical consultation services; medical analysis services relating to the treatment of patients; medical consultancy services; pharmacy advice being pharmaceutical consultation
Goods and ServicesScientific and technological services, namely, scientific research, analysis, testing in the fields of pharmaceuticals, biopharmaceuticals, chemistry, biology, biochemistry; industrial analysis services, namely, industrial analysis in the fields of pharmaceuticals, biopharmaceuticals; industrial research services in the fields of pharmaceuticals, biopharmaceuticals; scientific research and development; scientific research; scientific analysis, namely, biological analysis, biochemical analysis, chemical analysis; conducting chemical and biological analyses for scientific purposes; conducting medical analysis for scientific purposes, namely, biological analysis, biochemical analysis, chemical analysis, blood analysis; medical research; pharmaceutical research; research in the fields of chemistry and biology; biotechnological research services; providing medical and scientific research information, namely, providing information and data with respect to medical and veterinary research and development; providing information with respect to medical and scientific research in the field of pharmaceutical products; providing scientific information on research in the field of pharmaceutical products and biomedicine

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, May 1, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, January 4, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, January 4, 2022
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSynendos Therapeutics AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameSynendos Therapeutics AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameSynendos Therapeutics AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Monday, February 26, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, February 26, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, February 26, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, February 26, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, February 26, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, December 11, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, November 22, 2023FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, November 22, 2023FINAL DISPOSITION PROCESSED
Wednesday, November 22, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, August 22, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, August 22, 2023REGISTERED-PRINCIPAL REGISTER
Sunday, June 18, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Tuesday, June 6, 2023NOTIFICATION PROCESSED BY IB
Tuesday, June 6, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 6, 2023PUBLISHED FOR OPPOSITION
Wednesday, May 31, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, May 31, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, May 17, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, May 17, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, May 17, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, May 6, 2023CHANGE OF NAME/ADDRESS REC'D FROM IB
Monday, May 1, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, May 1, 2023EXAMINER'S AMENDMENT ENTERED
Monday, May 1, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, May 1, 2023EXAMINERS AMENDMENT E-MAILED
Monday, May 1, 2023EXAMINERS AMENDMENT -WRITTEN
Thursday, March 30, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 30, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 30, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 25, 2022REFUSAL PROCESSED BY IB
Saturday, October 1, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, October 1, 2022REFUSAL PROCESSED BY MPU
Thursday, August 25, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, August 24, 2022NON-FINAL ACTION WRITTEN
Monday, August 22, 2022ASSIGNED TO EXAMINER
Saturday, January 8, 2022APPLICATION FILING RECEIPT MAILED
Tuesday, January 4, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 30, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB